Annual report pursuant to Section 13 and 15(d)

Net Loss Per Share (Tables)

v3.22.0.1
Net Loss Per Share (Tables)
12 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following outstanding potentially dilutive ordinary shares (including Class A common stock and Class B common stock in 2021 and common stock in 2020 and 2019) were excluded from the computation of diluted net loss per share attributable to ordinary stockholders for the periods presented, as their effect would have been antidilutive:
Year ended December 31,
2021 2020 2019
(in thousands)
Redeemable convertible preferred stock —  40,843  31,145 
Stock options 10,601  6,289  5,514 
Restricted stock units 155  351  351 
Convertible preferred stock warrants and option —  2,347  412 
Other awards including contingently issuable shares 55  100  145 
Total anti-dilutive shares 10,811  49,930  37,567